Table 4.
Univariate and multivariate analysis of MACEs
| One-month MACE | Long-term MACE | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p Value | HR | 95% CI | p Value | |
| Univariable analysis | ||||||
| Age, years | 1.07 | 1.03–1.11 | 0.001 | 1.05 | 1.02–1.09 | 0.001 |
| Male, gender | 0.6 | 0.24–1.51 | 0.27 | 0.64 | 0.3–1.36 | 0.25 |
| previous MI | 1.82 | 0.25–13.48 | 0.56 | 2.32 | 0.56–9.65 | 0.25 |
| Killip class> 2 | 11.1 | 4.37–28.22 | 0.001 | 9.1 | 4.16–19.87 | 0.001 |
| Symptom to hospital time ≤ 3 h | 0.51 | 0.15–1.72 | 0.28 | 0.65 | 0.27–1.55 | 0.33 |
| Scr | 1.003 | 1–1.005 | 0.06 | 1.005 | 1–1.01 | 0.001 |
| Preserved LVEF | 0.15 | 0.04–0.65 | 0.01 | 0.31 | 0.13–0.74 | 0.01 |
| cTNT | 0.97 | 0.78–1.22 | 0.81 | 1.08 | 0.99–1.18 | 0.09 |
| Chronic total occlusion | 3.44 | 1.36–8.74 | 0.01 | 3.15 | 1.49–6.66 | 0.003 |
| LM lesion | 2.49 | 0.74–8.37 | 0.14 | 2.12 | 0.75–5.99 | 0.16 |
| TIMI grade0–1 | 3.88 | 1.70–8.86 | 0.001 | 2.4 | 1.21–4.77 | 0.01 |
| Multivariable analysis | ||||||
| Model 1 | ||||||
| TIMI grade 0–1 | 2.96 | 1.27–6.94 | 0.01 | 2.52 | 1.23–5.17 | 0.01 |
| Age | 1.06 | 1.02–1.11 | 0.003 | 1.04 | 1.01–1.08 | 0.01 |
| Killip class> 2 | 6.23 | 2.35–16.52 | 0.001 | 5.04 | 2.19–11.61 | 0.001 |
| Model 2 | ||||||
| TIMI grade 0–1 | 2.99 | 1.26–7.08 | 0.01 | 2.43 | 1.19–4.95 | 0.02 |
| Age | 1.05 | 1.02–1.09 | 0.01 | 1.04 | 1.01–1.07 | 0.01 |
| Killip class> 2 | 4.76 | 1.8–12.61 | 0.002 | 4.73 | 2.05–10.89 | 0.001 |
| Preserved LVEF | 0.24 | 0.05–1.03 | 0.06 | 0.41 | 0.17–1.01 | 0.05 |
| Chronic total occlusion | 3.26 | 1.26–8.43 | 0.02 | 3.48 | 1.6–7.56 | 0.002 |
| Scr | 1.003 | 1–1.007 | 0.09 | 1.006 | 1.004–1.007 | 0.001 |
LAD Left anterior descending artery, MACEs Major adverse cardiac events, MI Myocardial infarction, Scr Serum creatinine, cTNT Cardiac troponin T, LVEF Left ventricular ejection fraction, LM Left main artery, CTO Chronic total occlusion